Date:1/12/2010

gy companies new starting points for drug discovery and development, based on MRC advances in science. MRCT's Therapeutic Antibody Group scientists have a proven track record of success in antibody humanization which extends over 20 years and has produced 10 clinical candidates and two regulatory approved humanized antibodies: Elan/Biogen Idec's Tysabri(R) and Chugai/Roche's Actemra(R). http://www.mrctechnology.org

SOURCE Medical Research Council Technology (MRCT)

'/>"/>

SOURCE Medical Research Council Technology (MRCT) Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. International Isotopes Inc. Announces Submission of the License Application for Their Uranium De-conversion and Fluorine Extraction Processing Facility
2. Banfield, The Pet Hospital Signs Agreement to License APT's Test & Learn Management System
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada
5. Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend
6. Quantros Licenses Adverse Event Identification Technology from University of Michigan
7. Licensed Practical Nurses Have Role to Play in Fight Against Flu
8. Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
9. Professional HealthCare at Home Expands Services to Provide Licensed Hospice Care in Northern California
10. Stematix™ Obtains Exclusive License to Regenexx™ Stem Cell Procedure Treating Musculoskeletal Diseases in Latin America
11. Vicon Signs License Agreement with Microsoft to Develop New Medical Technology